Idenix Pharmaceuticals (IDIX)

[DewDiligence]

>You're having that reading comprehension problem again. The problem I saw was that Tyzeka WAS included in the current AASLD guidelines , and was specifically declared deficient.<

Don’t be such a smartass—you know perfectly well that when I said “included” I meant included with a positive recommendation. You also know—or should know—that a negative recommendation by AASLD is typical for a new drug that does not receive a positive recommendation; i.e., AASLD does not typically ignore a new hepatitis drug that has received FDA approval by pretending that it does not even exist.